Acute coronary syndromes

Cardiology (Switzerland)

Volumn 88, Issue 3, 1997, Pages 223-237

  Yun, Douglas D ^a   Alpert, Joseph S ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Acute coronary syndromes; Acute myocardial infarction; Coronary care; Reperfusion; Unstable angina

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRETYLIUM; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISOPYRAMIDE; FUROSEMIDE; GLYCERYL TRINITRATE; HEPARIN; LIDOCAINE; NITRATE; NITROPRUSSIDE SODIUM; PROCAINAMIDE; PROCAINE; QUINIDINE; SOTALOL; STREPTOKINASE; VERAPAMIL; WARFARIN;

ACUTE HEART INFARCTION; BRAIN HEMORRHAGE; CARDIOVERSION; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; DRUG COST; DRUG HYPERSENSITIVITY; EARLY DIAGNOSIS; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART RUPTURE; HEART SEPTUM DEFECT; HEART SURGERY; HEART VENTRICLE TACHYCARDIA; HUMAN; INCIDENCE; INDUSTRIALIZATION; INTRAVENOUS DRUG ADMINISTRATION; JUGULAR VEIN; LUNG EMBOLISM; MITRAL VALVE REGURGITATION; MORTALITY; ORAL DRUG ADMINISTRATION; PERICARDITIS; PRIORITY JOURNAL; PROGNOSIS; Q WAVE; REVIEW; THROMBOEMBOLISM; UNSTABLE ANGINA PECTORIS;

EID: 0030904429     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000177335     Document Type: Article

References (64)

1. American Heart Association: 1990 Heart Facts. Dallas. American Heart Association National Center, 1995. p 1.
2. Grambow DW. Topol EJ: Effect of maximal medical therapy on refractoriness of unstable angina pectoris. Am J Cardiol 1992:70:577-581.
3. Fusler V. Badimon L. Cohen M. Ambrose JA. Badimon JJ. Chescbro J: Insights into the pathogenesis of acute ischemic syndromes. Circulation 1988:77:1213-1220.
4. Shah PK. Forrester JS: Pathophysiology of acute coronary syndromes. Am J Cardiol 1991: 68:16C-21C.
5. Davies MJ. Thomas AC: Plaque Assuring-The cause of acute myocardial infarction, sudden ischemic death, and crescendo angina. Br Heart J 1985;53:363-373.
6. Braunwald E: Unstable angina: A classifica-lion. Circulation 1989;80:410-414.
7. McClellan JR: Unstable angina: Prognosis, noninvasive risk assessment, and strategies for management. Clin Cardiol 1994:17:229-238.
8. Braunwald E. Jones RH. Mark DB. Brown J. Brown E. Chcitlin MD. Concannon CA. et al: Diagnosing and managing unstable angina. Circulation 1994;90:613-622.
9. Lewis HD. Davis JW. Archibald DG. Steinke WE. Smitherman TC, Doherty JE. Sehnaper HW. LeWintcr MM. Linares E. Pouget JM. Sabharwal SC. Chesler E. DeMots H: Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. N Engl J Med 1983;309:396-403.
10. −KJ. Frog-gatt GM. Holder DA. Jablonsky G. Kostuk J. Melendez LJ. Myers MG. Sackett DL. Scalcy BJ, Tanser PH: Aspirin, sulfinpyrazone, or both in unstable angina. N Engl J Med 1985: 313:1369-1375.
11. RISC Group: Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 1990:336: 827-830.
12. Serneri GGN. Gensini G. Poggcsi L, Trotta F. Modesti PA, Boddi M, leri A. Margheri M, Casolo GC. Mini M. Rostagno C. Carnovali M. Abbate R: Effect of heparin, aspirin, or alte-plase in reduction of myocardial ischemia in refractory unstable angina. Lancet 1990:335: 615-618
13. Theroux P. Qui S. McCans J. Lidon RM. Waters D: Effect of heparin upon the frequency of transient myocardial ischemia during the acute phase of unstable angina. Circulation 1992; 86(suppl I):1-385.
14. Holdright DR. Sparrow JD. Wright CA, Wicks M. Pierccll H. Hubbard W, Sutton GC. Hendry G, Fox KM: The effects of heparin on myocardial ischemia in unstable angina. Circulation 1992:86(suppl I):1-385.
15. Theroux P. Waters D. Qui S. McCans J. de Guise P. Juneau M: Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina. Circulation 1993: 88(pt 11):2045-2048.
16. Freeman MR. Langer A. Wilson RF. Morgan C. Armstrong PW: Thrombolysis in unstable angina. Circulation 1992:85:150-157.
17. Schrciber TL. Rizik D, White C. Sharma GWK. Cowley M. Macina G. Reddy PS. et al: Randomized trial of thombolysis versus heparin in unstable angina. Circulation 1992:86: 1407-1414.
18. Lubsen J: Medical management of unstable angina. Circulation 1990;82(suppl): 11-82-11-87.
19. Waters D. Lam J. Theroux P: Newer concepts in the treatment of unstable angina pectoris. Am J Cardiol 1991;68:34C-41C.
20. The TIMI IIIB Investigators: Effects of lissue plasminogen activator and a comparison of early invasive and conservative strategics in unstable angina and non-Q wave myocardial infarction. Circulation 1994:89:1545-1556.
21. Killip T. Kimball JT: Treatment of myocardial infarction in a coronary care unit. Am J Cardiol 1967:20:457-464.
22. Brush JE. Brand DA, Acampora D. Chalmer B. Wackers FJ: Use of the initial electrocardiogram to predict in-hospital complications of acute myocardial infarction. N Engl J Med 1985;312:1137-1141.
23. Adams JE, Abendschein DR. Jaffe AS: Biochemical markers of myocardial injury: Is MB creatinine kinase the choice for the 1990s? Circulation 1993:88:750-762.
24. Murray C. Alpcrt JS: Diagnosis of acute myocardial infarction. Curr Opin Cardiol 1994:9: 465-470.
25. Adams JE. Bodor GS. Davila-Roman VG. Del-mez JA. Apple FS. Ladcnson JH. Jaffe AS: Cardiac troponin I: A marker with high specificity for cardiac injury. Circulation 1993:88:101-106.
26. Alpert JS: Importance of the pharmacological profile of thrombolytic agents in clinical practice. Am J Cardiol 1991:67:3H-7H.
27. European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator: Randomized trial of intravenous recombinant tissue-type activator versus intravenous streptokinase in acute myocardial infarction. Lancet 1985:i:842-847.
28. Chesbro JH, Knatterud G. Roberts R: Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Circulation 1987:76:142-154.
29. The GUSTO Angiographic Investigators: The effects of tissue plasminogen activator, streptokinase. or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993:329: 1615-1622.
30. Gruppo Italiano per lo Studio della Stretochi-nasi nell’Inlarto Miocardico (GISSI): Longterm effects of intravenous thrombolysis in acute myocardial infarction; Final report of the GISSI study. Lancet 1987;ii:871-874.
31. ISIS-2 Collaborative Group: Randomized trial of intravenous streptokinase, oral aspirin, or neither among 17.187 cases of suspected acute myocardial infarction. Lancet 1988:i:349-360.
32. LATE Study Group: late assessment of thrombolytic efficacy (LATE) study with alteplase after onset of acute myocardial infarction. Lancet 1993:342:759-766.
33. Tiefcnbrunn AJ. Ludbrook PA: Coronary thrombolysis-it’s worth the risk? JAMA 1989: 261:2107-2108.
34. Califf RM. Topol EJ. George BS. et al: Hentor-rhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction. Am J Med 1988:85:353-359.
35. Grincs CL. Browne KF. Marco J. et al: A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993:326:673-693.
36. Bosker HA. van dcr Laarse A, Cats VM. Bruschke AVG: Are enzymatic tests good indicators of coronary reperfusion? Br Heart J 1992.67:150-154.
37. Califf RM. O’Neill W. Stack RS. et al: Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis. Ann Intern Med 1988:108:658-662.
38. Fernandez AR. Sequeira RF. Chakko S. Correa LF. de Marchcna EJ, Chahine RA. Franceour DA. Mverburg RJ: ST segment tracking for rapid determination of patency of the infarct-rclatcd artery in acute myocardial infarction. J Am Coll Cardiol 1995;26:675-683.
39. Stack RS. O'Connor CM. Mark DB. et al: Coronary perfusion during acute myocardial infarction with a combined therapy of coronary angioplasty and high-dose intravenous streptokinase. Circulation 1988:77:151-161.
40. Topd EJ. Califf RM. Georges BS. et al.: A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 1987:317:581-588.
41. TIMI Research Group: Immediate versus delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. JAMA 1988:260:2849-2858.
42. The TIMI Study Group: Comparison of invasive and conservative strategics after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II trial. N Engl J Med 1989;320:618-627.
43. Roberts R. Rogers WJ. Mueller HS. Lambrew CT. Diver DJ. Smith HC. Willcrson JT: Immediate versus deferred beta blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the thrombolysis in myocardial infarction: TIMI II-B Study. Circulation 1991;83:422-437.
44. Gibson RS: Current status of calcium channelblocking drugs after Q wave and non-Q wave myocardial infarction. Circulation 1989: 80(suppl IV):IV-107-IV-119.
45. Gibson RS. Young PM. Roden WE, Schecht-man K. Roberts R: Prognostic significance and beneficial effect of diltiazem on the incidence of early recurrent ischemia after non-Q wave myocardial infarction: Results from the Multi-center Diltiazem Reinfarction Study. Am J Cardiol 1987:60:203-209.
46. The Danish Study Group on Verapamil in Myocardial Infarction: Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial 11-DAVIT 11). Am J Cardiol 1990:66: 779-785.
47. Gruppo Italiano per lo Studio della Sopravi-venza nell'lnfarto Miocardico(GlSSI-3): Effect of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994:343:1115-1122.
48. Abrams J: New perspectives on nitrate use in acute MI, J Myocardiol Ischemia 1995:7:194-201.
49. Waugh RA. Wagner GS. Haney TL, Rosati RA. Morris JJ: Immediate and remote prognostic significance of fascicular block during acute myocardial infarction. Circulation 1973: 47:765-775.
50. DeSanctis RW. Block P. Hutter AM: Tachyarrhythmias in myocardial infarction. Circulation. 1972:45:681-702.
51. Manning WJ. Silverman DI. Gordon SPI, Krumholz HM. Douglas PS: Cardioversion from atrial fibrillation without prolonged anti-coagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi. N Engl J Med 1993:328:750-755.
52. Hine LK. Laird N. Hewitt P. Chalmers TC: Meta-analvtic evidence against prophylactic uscoflidocainc in acute myocardial infarction. Arch Intern Med 1989:149:2694-2698.
53. Cohn LE:Surgical management of acute and chronic cardiac mechanical complications due to myocardial infarction. Am Heart.J 1981: 102:1049-1060.
54. Lcmcry RL. Smith HC. Giuliani ER. Gersh BJ: Prognosis in rupture of the ventricular septum alter acute myocardial infarction and role of early surgical intervention. Am J Cardiol 1992: 70:147-151.
55. Scanlon PJ. Montoya A, Johnson SA. McKce-ver LS, Sullivan HJ. Bakhos M. Pifarre R: Urgent surgery for ventricular septal rupture complicating acute myocardial infarction. Circulation 1985:72(suppl): 11-185-11-190.
56. Klein HO. Tordjman T, Ninio R, Sareli P. Oren V. Lang R. Gefcn J. Pauzner C. Di Segni E. David D. Kapiinsky E: The early recognition of right ventricular infarction: Diagnostic accuracy of the electrocardiographic V4R lead. Circulation 1983:67:558-564.
57. Kulbertus HE. Rigo P. Legrand V: Right ventricular infarction: Pathophysiology, diagnosis, clinical course, and treatment. Mod Concepts Cardiovasc Dis 1985:54:1-5.
58. Lichstein E. Liu H, Gupta P: Pericarditis complicating acute myocardial infarction: Incidence of complicat ions and significance of electrocardiogram on admission. Am Heart J 1974: 87:246-252.
59. Berman J. Haffajee CI. Alpcrt JS: Therapy of symptomatic pericarditis after myocardial infarction: Retrospective and prospective studies of aspirin, indomethacin. prednisone, and spontaneous resolution. Am Heart J 1981:101: 750-753.
60. The PIOPED Investigators: Value of the ventilât ion/perfusion scan in acute pulmonary embolism: Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 1990;263:2753-2759.
61. Domingo E. Bardaji A. Angel J. Soler-Solcr J: Postntyocardial infarction left ventricular thrombus: An unusual cause of transient intractability of heart failure. Chest 1986:89: 898-900.
62. Shapira I, Isakov A. Burke M. Almog Ch: Cardiac rupture in patients with acute myocardial infarction. Chest 1987;92:219-222.
63. March KL. Sawada SG. Tarver RD. Kesler KA. Armstrong WF: Current concepts of left ventricular pseudoaneurysm: Pathophysiology, therapy, and diagnostic imaging methods. Clin Cardiol 1989;12:531-540.
64. The SAVE Investigators: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992:327: 669-677.